Two decades of real-world data
Enhanced Scrutiny of DTC Prescription Drug Advertising Ensnares More Telehealth Firms What is happening: FDA issued a press release on March 3, 2026 to highlight the public posting of more than two dozen warning letters it sent to various telehealth companies in late February, an action widely seen as a continuation of the agencys self-declared crackdown on direct-to-consumer (DTC) drug advertising that began in September 2025
For this reason, they may need to move more quickly than other employers to determine a coverage approach
The authors wish to thank Ms
K., Boareto, M., Huang, B., Jia, D., Lu, M., Ben-Jacob, E., et al
16 people found this review helpful Hi Vawn, Sorry for your inconvenience